EFSD/Sanofi Outlook to the next 100 Years of Insulin: Innovative Insulin Delivery and Monitoring Systems

Closing Date: 01/03/2022

Funding available to stimulate and accelerate European research aimed at understanding and improving insulin delivery and action.

The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly disseminate acquired knowledge and to promote its application.

Sanofi is a global and diversified healthcare leader in the development and distribution of therapeutic solutions focused on patients’ needs.

EFSD and Sanofi have established the Outlook to the next 100 Years of Insulin: Innovative Insulin Delivery and Monitoring Systems programme to stimulate and accelerate European research aimed at understanding and improving insulin delivery and action.

Grants are offered for basic and clinical mechanistic studies understanding and improving insulin delivery and action. Grants are offered for basic, clinical-experimental studies, specifically with translation concepts aiming at exploiting existing technology as well as identifying innovative approaches for insulin delivery systems and monitoring insulin therapy.

Funding body European Foundation for the Study of Diabetes (EFSD)
Maximum value €100,000
Reference ID S23096
Category Engineering and Physical Sciences
Medical Research

Fund or call Fund